![Katarina Luptakova](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Katarina Luptakova
Inga fler pågående positioner
Förmögenhet: 21 636 $ per 2026-07-31
Profil
Katarina Luptakova worked at Tesaro, Inc. from 2017 to 2020, serving as Senior Medical Director from 2018 to 2020.
From 2020 to 2021, worked at Constellation Pharmaceuticals, Inc. as Vice President-Clinical Development.
From 2022 to 2023, worked at Xilio Therapeutics, Inc. as Senior Vice President-Medical.
Education includes a doctorate from the University of Commenius.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
XILIO THERAPEUTICS INC 0,04 % | 2026-01-02 | 2 375 ( 0,04 % ) | 21 636 $ | 2026-07-31 |
Tidigare kända positioner av Katarina Luptakova
| Företag | Position | Slut |
|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | Företagsledare/Principal | 2021-10-01 |
| TESARO INC | Teknisk/Vetenskaplig/F&U Direktör | 2020-04-01 |
| XILIO THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Katarina Luptakovas utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
52
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
University of Commenius
 University of Commenius Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
